Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT03850730 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Hemorrhagic Telangiectasia
Epistaxis

Interventions

DRUG: Pazopanib

Sponsor

Cure HHT

Collaborators

[object Object]